The insider sales are too small to signal a material change in outlook. Monitor for any upcoming clinical data readouts or regulatory catalysts that could drive the stock, as the company is a clinical-stage biotech. The CEO's sale may be routine portfolio diversification.
Price Chart
Executive Summary
CEO Jon Congleton and CMO David Malcom Rodman sold a combined ~$302K in MLYS stock over a 7-day window, with the CEO's $291K sale representing the bulk. The sales are modest relative to the $2.2B market cap (~0.014%), and the CMO's trades include a same-day derivative exercise and sale, suggesting tax-related or liquidity-driven selling rather than a bearish signal. The cluster is small in dollar terms and lacks the materiality to indicate informed selling.
Key Financial Metrics
Key Facts
- CEO Jon Congleton sold 10,700 shares for ~$291K on 2026-07-13
- CMO David Malcom Rodman sold 416 shares for ~$11K on 2026-07-17, following a derivative exercise
- Total insider sales of ~$302K represent ~0.014% of MLYS's $2.2B market cap
- CMO also exercised 416 derivative shares at $15.44 on 2026-07-17, a non-cash event
- No open-market insider purchases were reported in the cluster window
Financial Impact
Insider sales of ~$302K are immaterial relative to $2.2B market cap
Risk Factors
- Insider selling, while small, could be perceived negatively by retail investors
- Clinical-stage biotech risk: no approved products, reliance on pipeline success
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MLYS-1784595659581 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 12, 2026 7w ago | 3 | $26.09 $28.20 | ▲ +8.09% | ▲ +9.83% | $23.56 (−9.70%) |
Jul 23, 2026 10w ago | Insider Cluster | $26.71 $25.65 | ▼ −3.97% | ▼ −7.59% | $23.56 (−11.79%) |
Jul 21, 2026 10w ago | Insider Cluster | $27.52 $26.61 | ▼ −3.31% | ▼ −5.87% | $23.56 (−14.39%) |
Jul 16, 2026 11w ago | Insider Cluster | $27.08 $26.09 | ▼ −3.66% | ▼ −7.27% | $23.56 (−13.00%) |
Jun 30, 2026 13w ago | 144 | $26.89 $26.35 | ▼ −2.01% | ▲ +0.18% | $23.56 (−12.38%) |
Jun 29, 2026 13w ago | 144 | $26.88 $26.71 | ▼ −0.63% | ▼ −0.35% | $23.56 (−12.35%) |
Jun 18, 2026 15w ago | Insider Cluster | $24.63 $27.08 | ▲ +9.95% | ▲ +9.41% | $23.56 (−4.34%) |
Jun 17, 2026 15w ago | 144 | $24.63 $27.08 | ▲ +9.95% | ▲ +9.41% | $23.56 (−4.34%) |
Jun 11, 2026 16w ago | Institutional Cluster | $23.94 $28.96 | ▲ +20.97% | ▲ +19.08% | $23.56 (−1.59%) |
Jun 3, 2026 17w ago | 8-K | $25.06 $27.69 | ▲ +10.49% | ▲ +11.49% | $23.56 (−5.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access